Drug discovery is a long and difficult process. As a CRO for preclinical drug development in the field of ophthalmology, Ace Therapeutics offers a full range of small molecule ophthalmic drug discovery services, supporting every stage from target designation to drug candidate selection. We offer a suite of cutting-edge technologies and deep expertise to bring value to every stage of your ophthalmic drug discovery project, from hit identification to lead optimization.
Drug discovery is a long and difficult process. Throughout the drug discovery process, recent advances in chemistry have increased the efficiency of compound synthesis, chemical libraries can generate and store volume and diversity data synthetically, and high-throughput screening of various molecules is employed to identify pairs of targets and pathways that are the main compounds with therapeutic activity. Today, the steps of drug discovery and development involve screening hits, iterating medicinal chemistry, and optimizing hits to reduce potential drug side effects (increase affinity and selectivity). During these steps, the potency, metabolic stability (half-life), and oral bioavailability of the drug are also improved. Ophthalmic disease is a complex disease involving different locations of the fundus and ocular surface. The discovery and research of small molecule targeted drugs can help identify protein targets and better understand disease mechanisms.
Ace Therapeutics is the CRO for preclinical drug development in the field of ophthalmology. We provide a full range of preclinical small molecule targeted drug discovery services, supporting you at every stage from disease target designation to drug candidate selection. When you outsource target identification, hit identification, hit to lead, lead optimization, and in vivo/in vitro safety pharmacology studies to our expert team, it will greatly save your time. Our dedicated team of all-round professionals will work with you to deliver tailored scientific solutions that add significant value to your drug discovery project. You have reason to believe that we are your most reliable partner.
At Ace Therapeutics, we offer a suite of cutting-edge technologies and a wealth of expertise to bring value to every stage of your ophthalmic drug discovery project, from hit identification to lead optimization. We are committed to maximizing the efficiency of our global clients' drug discovery projects in ophthalmology. There is no doubt that our skilled professional consultants and efficient processes will accelerate your drug development research projects.
Ace Therapeutics provides the following technical support and services for global customers' ophthalmic small molecule targeted drug development, including but not limited to.
As a CRO with decades of experience in ophthalmic preclinical drug development, Ace Therapeutics helps our clients seamlessly transition to the IND phase within budget.
Working closely with Ace Therapeutics, you will benefit from our fast, reliable and cost-effective integrated ophthalmic small molecule targeted drug discovery services. Our drug discovery service team will provide you with the most suitable solution based on your project's specific requirements. For more information, please feel free to contact us.
Reference